Evidence-Based Compounds for Insomnia
Insomnia affects an estimated 10–30% of adults and is driven by dysregulation of circadian rhythm, GABA signalling, cortisol excess, and melatonin deficiency. Research from over 1 million PubMed studies identifies compounds that improve sleep onset latency, sleep efficiency, and sleep architecture without the dependency risks of pharmaceutical hypnotics.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001